Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Pancreatic Neoplasms: HELP
Hardik R. Mody
Based on 5 articles published since 2010
(Why 5 articles?)
||||
Expertise Level
The expertise of Hardik R. Mody ranks in the
  • Top 3.5%
  • ... of 104,375 published authors worldwide on Pancreatic Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 5 articles on the topic.
Graphical view (beta)
Aliases Mody, Hardik   ·   Mody, Hardik R
Work Locations
Details
Most likely:    University of Georgia      
2017
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, OH, USA. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, GA, USA. · Department of Biochemistry and Molecular Biology, The University of Georgia, Athens, GA, USA. · The Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. · Pubmed 28978088
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, Georgia. · The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University, Columbus, Ohio. · Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Pubmed 28373289
2016
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, Georgia. · The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Pubmed 27624777
2013
  • Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, Georgia, United States of America. · Pubmed 23940717
2012
  • Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA 30602, USA. · Pubmed 22425961
Probable:    Ohio State University   Contact    
2017
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, OH, USA. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, GA, USA. · Department of Biochemistry and Molecular Biology, The University of Georgia, Athens, GA, USA. · The Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. · Pubmed 28978088
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, Georgia. · The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University, Columbus, Ohio. · Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Pubmed 28373289
2016
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, Georgia. · The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Pubmed 27624777
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Hardik R. Mody in 2010-2020 about Pancreatic Neoplasms:

  • SET contributes to the epithelial-mesenchymal transition of pancreatic cancer. 2017
  • miR-202 Diminishes TGFβ Receptors and Attenuates TGFβ1-Induced EMT in Pancreatic Cancer. 2017
  • Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p. 2016
  • Pharmacological reversal of histone methylation presensitizes pancreatic cancer cells to nucleoside drugs: in vitro optimization and novel nanoparticle delivery studies. 2013
  • Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge. 2012
Show List of Full Article Records
Google Searches

Learn more about Hardik R. Mody using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Georgia
Ohio State University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Georgia
2017
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, OH, USA. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, GA, USA. · Department of Biochemistry and Molecular Biology, The University of Georgia, Athens, GA, USA. · The Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. · Pubmed 28978088
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, Georgia. · The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University, Columbus, Ohio. · Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Pubmed 28373289
2016
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, Georgia. · The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Pubmed 27624777
2013
  • Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, Georgia, United States of America. · Pubmed 23940717
2012
  • Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA 30602, USA. · Pubmed 22425961
Ohio State University
2017
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, OH, USA. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, GA, USA. · Department of Biochemistry and Molecular Biology, The University of Georgia, Athens, GA, USA. · The Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. · Pubmed 28978088
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, Georgia. · The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The Ohio State University, Columbus, Ohio. · Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Pubmed 28373289
2016
  • Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, Ohio. · Department of Pharmaceutical and Biomedical Sciences, The University of Georgia, Athens, Georgia. · The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Pubmed 27624777
Yearly article counts 00021001100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.